Automated CRISPRa Epigenetic Reprogramming Foundry Cleanroom Cap Rate 2026

Underwrite GMP Class A/B continuous synthetic dCas9-VPR activation vectors and epigenetic cellular rejuvenation vector suites, $550/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

CRISPRa Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP CRISPRa Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation